SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TGEN - Targeted Genetics Corporation
TGEN 8.230+0.9%Nov 7 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike McFarland who wrote (421)11/4/2004 5:11:50 PM
From: Mike McFarland of 557
 
somewhat OT...but ISPH was up 13% on three
times average volume. I will try to listen
to the CC sometime this evening.
inspirepharm.com

The thread does not seem to be active here
on SI...if not for surfing the CFF website
I would not probably have even noticed it today.

this is a few weeks old...but as I said, I will
try to get to the call and post to ISPH thread.
cff.org
Christy L. Shaffer, Ph.D., CEO of Inspire Pharmaceuticals, Inc., shared recent positive results from clinical trials of INS37217, a novel drug that bypasses the defective CFTR protein channel and turns on an alternative system that stimulates salt and water balance in the CF cell environment Continued analysis of Phase II data shows promising results, and Phase III will be designed in the next few months.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext